EXEMESTANE
Generic: EXEMESTANE
Cipla USA Inc.Manufacturer
ORALRoute
EXEMESTANEActive Substance
2018-04-27Original Approval
EXEMESTANE is FDA application ANDA210323, sponsored by CIPLA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FATIGUE
1,495 reports
2
MALIGNANT NEOPLASM PROGRESSION
1,418 reports
3
DIARRHOEA
1,249 reports
4
NAUSEA
1,215 reports
5
DYSPNOEA
967 reports
6
ARTHRALGIA
957 reports
7
ASTHENIA
745 reports
8
COUGH
744 reports
9
HEADACHE
733 reports
10
VOMITING
710 reports